Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.

Literature DB >> 7275323

Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.

A B Bjornson, J S Lobel, P I Magnafichi, B C Lampkin.

Abstract

Supplementation of sera from four children with sickle cell disease with untreated or heated normal human serum or with normal human immunoglobulin G restored opsonic activity for serotype 10 Streptococcus pneumoniae, whereas supplementation with normal human immunoglobulin M did not.

Entities: Species

Mesh：

Substances：

Year: 1981 PMID： 7275323 PMCID： PMC350749 DOI： 10.1128/iai.33.2.636-640.1981

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

27 in total

1. Deficiency of factor B of the complement system in sickle cell anaemia.

Authors: W A Wilson; G R Hughes; P J Lachmann
Journal: Br Med J Date: 1976-02-14

2. Prospective study of sickle cell anemia in infancy.

Authors: R T O'Brien; S McIntosh; G T Aspnes; H A Pearson
Journal: J Pediatr Date: 1976-08 Impact factor: 4.406

3. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.

Authors: J A Winkelstein; R H Drachman
Journal: N Engl J Med Date: 1968-08-29 Impact factor: 91.245

4. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

5. Impaired antibody response to intravenous immunization in sickle cell anemia.

Authors: A D Schwartz; H A Pearson
Journal: Pediatr Res Date: 1972-02 Impact factor: 3.756

6. Functional asplenia in sickle-cell anemia.

Authors: H A Pearson; R P Spencer; E A Cornelius
Journal: N Engl J Med Date: 1969-10-23 Impact factor: 91.245

7. Alternative complement pathway activity in sera from patients with sickle cell disease.

Authors: S M Koethe; J T Casper; G E Rodey
Journal: Clin Exp Immunol Date: 1976-01 Impact factor: 4.330

8. An abnormality of the alternate pathway of complement activation in sickle-cell disease.

Authors: R B Johnston; S L Newman; A G Struth
Journal: N Engl J Med Date: 1973-04-19 Impact factor: 91.245

9. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.

Authors: J A Winkelstein; H S Shin
Journal: J Immunol Date: 1974-05 Impact factor: 5.422

10. Alternative pathway of complement in sickle cell disease.

Authors: R G Strauss; T Asbrock; J Forristal; C D West
Journal: Pediatr Res Date: 1977-04 Impact factor: 3.756

3 in total

1. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.

Authors: A Nowak-Wegrzyn; J A Winkelstein; A J Swift; H M Lederman
Journal: Clin Diagn Lab Immunol Date: 2000-09

2. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.

Authors: A B Bjornson; J S Lobel
Journal: J Clin Invest Date: 1987-02 Impact factor: 14.808

Review 3. The multifaceted view of heart problem in Duchenne muscular dystrophy.

Authors: Urszula Florczyk-Soluch; Katarzyna Polak; Józef Dulak
Journal: Cell Mol Life Sci Date: 2021-06-06 Impact factor: 9.261

3 in total